Artwork for podcast Pathfinders in Biopharma
Ionis: Raising The Bar For ESG
Episode 928th October 2021 • Pathfinders in Biopharma • RBC Capital Markets
00:00:00 00:23:46

Share Episode


In this episode of Pathfinders, Luca Issi, Senior Biotech Analyst at RBC Capital Markets, speaks with Beth Hougen, CFO of Ionis – a leading innovator in the development of antisense medicines and RNA-targeted therapeutics – to find out how the firm is embedding ESG into its vision, strategy and performance.